Additional file 1: Supplemental Figure 1. Overall survival with receiving treatment at academic centers (red) or non-academic center (blue) for (A) patients who did not receive surgery or chemotherapy
Aims and objective: To estimate the effect of losartan 50 mg on survival of post-dialysis euvolemic hypertensive patients. Methodology: A single center, prospective, single
